Skip to content

Leuprolide clinical trials: 162 trials

Page 2 of 4

  1. Regulation of Cervical Mucus Secretion

    NCT02969590 · Phase 4 · Completed

    Posted results

  2. External Beam Radiation With or Without Chemotherapy to Treat High Risk Prostate Cancer

    NCT01603420 · Phase 2/3 · Terminated

    Posted results

  3. RADAR Trial - Randomised Androgen Deprivation and Radiotherapy

    NCT00193856 · Phase 3 · Completed

    Linked paper with results

  4. A Phase IIIb Study of Intermittent Versus Continuous Hormone Deprivation Treatment With ELIGARD

    NCT00378690 · Phase 3 · Completed

    Linked paper with results

  5. Efficacy and Safety of Medication Used to Stimulate Ovulation

    NCT02715336 · Phase 4 · Status unknown

    Linked paper with results

  6. Short Versus Long-term Androgen Deprivation Therapy With Salvage Radiotherapy in Prostate Cancer. URONCOR 0624

    NCT05781217 · Phase 3 · Recruiting

    Linked paper with results

  7. Clinical Study to Evaluate Efficacy and Safety of TAK-385 40 mg Compared With Leuprorelin in Patients With Endometriosis

    NCT03931915 · Phase 3 · Completed

    Linked paper with results

  8. Leuprolide Acetate 3.75 mg Depot to Treat Prostate Cancer

    NCT00128531 · Phase 3 · Completed

    Linked paper with results

  9. Implant and External Radiation for Prostate Cancer With or Without Hormonal Therapy: A Prospective Randomized Trial

    NCT00243646 · Phase 3 · Terminated

    Linked paper with results

  10. Treatment of Uterine Fibroids With Magnetic Resonance Guided High Intensity Focused Ultrasound

    NCT02736435 · Phase 3 · Withdrawn

    Linked paper with results

  11. Study Assessing the Efficacy and Safety of Alpelisib Plus Fulvestrant or Letrozole, Based on Prior Endocrine Therapy, in Patients With PIK3CA Mutant, HR+, HER2- Advanced Breast Cancer Who Have Progressed on or After Prior Treatments

    NCT03056755 · Phase 2 · Completed

    Posted results

  12. Bay98-7196, Dose Finding / POC Study

    NCT02203331 · Phase 2 · Completed

    Posted results

  13. Bicalutamide and Goserelin or Leuprolide Acetate With or Without Cixutumumab in Treating Patients With Newly Diagnosed Metastatic Prostate Cancer

    NCT01120236 · Phase 2 · Completed

    Posted results

  14. Neoadjuvant Study Chemotherapy vs Letrozole + Abemaciclib in HR+/HER2- High/Intermediate Risk Breast Cancer Patients

    NCT04293393 · Phase 2 · Active, not recruiting

    Posted results

  15. A Study of Salvage Radiotherapy With or Without Enzalutamide in Recurrent Prostate Cancer Following Surgery

    NCT03809000 · Phase 2 · Active, not recruiting

    Posted results

  16. Efficacy and Safety Study of Elagolix Versus Placebo or Leuprorelin Acetate in Endometriosis

    NCT00797225 · Phase 2 · Completed

    Posted results

  17. Effect of GTx-758 on Total and Free Testosterone Levels in Men With Prostate Cancer

    NCT01326312 · Phase 2 · Terminated

    Posted results

  18. A Phase 2 Study to Evaluate the Safety and Efficacy of TAK-385, Together With a Leuprorelin Observational Cohort, in Participants With Prostate Cancer

    NCT02083185 · Phase 2 · Completed

    Posted results

  19. Neoadjuvant And Adjuvant Abiraterone Acetate + Apalutamide Prostate Cancer Undergoing Prostatectomy

    NCT02903368 · Phase 2 · Completed

    Posted results

  20. Hormone Therapy and Ipilimumab in Treating Patients With Advanced Prostate Cancer

    NCT00170157 · Phase 2 · Completed

    Posted results

  21. Docetaxel With Rapid Hormonal Cycling as a Treatment for Patients With Prostate Cancer

    NCT00587431 · Phase 2 · Completed

    Posted results

  22. Effects of IAS in Men With Localized Biochemical Relapsed Prostate Cancer

    NCT00223665 · Phase 2 · Completed

    Posted results

  23. The Effects of Reproductive Hormones on Mood and Behavior

    NCT00001322 · Phase 1/2 · Completed

    Posted results

  24. Melanoma Vaccine With Peptides and Leuprolide

    NCT00254397 · Phase 2 · Completed

    Posted results

  25. RElugolix VErsus LeUprolide Cardiac Trial

    NCT05320406 · Phase 2 · Active, not recruiting

    Posted results

  26. The Role of Highly Selective Androgen Receptor (AR) Targeted Therapy in Men With Biochemically Relapsed Hormone Sensitive Prostate Cancer

    NCT01790126 · Phase 2 · Completed

    Posted results

  27. Hormone Ablation Therapy, Doxorubicin, and Zoledronate With or Without Strontium 89 in Treating Patients With Androgen-Dependent Prostate Cancer and Bone Metastases

    NCT00081159 · Phase 2 · Completed

    Posted results

  28. Pilot Study of Leuprolide to Improve Immune Function After Allogeneic Bone Marrow Transplantation

    NCT01338987 · Phase 2 · Completed

    Posted results

  29. Enzalutamide/Leuprolide +/- Abiraterone/Pred in Prostate

    NCT02268175 · Phase 2 · Completed

    Posted results

  30. Salvage Radiotherapy Combined With Hormonotherapy in Oligometastatic Pelvic Node Relapses of Prostate Cancer

    NCT02274779 · Phase 2 · Completed

    Posted results

  31. The Role of Hormones in Postpartum Mood Disorders

    NCT00001481 · Phase 2 · Completed

    Posted results

  32. A Phase II Study of Androgen Deprivation Therapy With or Without Palbociclib in RB-Positive Metastatic Prostate Cancer

    NCT02059213 · Phase 2 · Completed

    Posted results

  33. LHRH Analogue Therapy With Enzalutamide or Bicalutamide in Treating Patients With Hormone Sensitive Prostate Cancer

    NCT02058706 · Phase 2 · Completed

    Posted results

  34. Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer

    NCT01431391 · Phase 2 · Completed

    Posted results

  35. Neo-adjuvant Abiraterone + Luteinizing Hormone-Releasing Hormone (LHRH) Versus LHRH in Prostate Cancer

    NCT01088529 · Phase 2 · Completed

    Posted results

  36. AASUR in High Risk Prostate Cancer

    NCT02772588 · Phase 2 · Completed

    Posted results

  37. GnRH Analogue for Ovarian Function Preservation in Hematopoietic Stem Cell Transplantation Patients

    NCT00429494 · Phase 2 · Completed

    Posted results

  38. A Phase 2 Study to Evaluate Safety and Efficacy of Abiraterone Acetate in Male Participants With Prostate Cancer

    NCT00924469 · Phase 2 · Completed

    Posted results

  39. Supportive Therapy in Androgen Deprivation Clinic in Improving Health Outcomes and Managing Side Effects in Patients With Prostate Cancer

    NCT02168062 · Phase 2 · Terminated

    Posted results

  40. Apalutamide and Leuprolide in Intermediate and High-risk Prostate Cancer

    NCT02770391 · Phase 2 · Completed

    Posted results

  41. Study of Enzalutamide (Formerly MDV3100) as a Neoadjuvant Therapy for Patients Undergoing Prostatectomy for Localized Prostate Cancer

    NCT01547299 · Phase 2 · Completed

    Posted results

  42. Phase II Study of Subcutaneous Injection Depot of Leuprolide Acetate in Patient With Prostate Cancer

    NCT02212197 · Phase 2 · Completed

    Posted results

  43. Nivolumab + Docetaxel + ADT in mHSPC Patients With DDRD or Inflamed Tumors

    NCT04126070 · Phase 2 · Active, not recruiting

    Posted results

  44. Zometa on Bone Mineral Density in Prostate Cancer Patients Undergoing Androgen Ablation Therapy

    NCT00582556 · Phase 2 · Completed

    Posted results

  45. Docetaxel, Bevacizumab and Androgen Deprivation Therapy After Definitive Local Therapy for Prostate Cancer

    NCT00658697 · Phase 2 · Completed

    Posted results

  46. S0032, Combination Chemotherapy Plus Hormone Therapy in Treating Patients With Metastatic Prostate Cancer

    NCT00028769 · Phase 2 · Completed

    Posted results

  47. Neoadjuvant Hormones + Docetaxel in Node-Positive Prostate Cancer

    NCT01076335 · Phase 2 · Completed

    Posted results

  48. Hormonal Ablation, Imatinib Mesylate and Docetaxel for Patients With Prostate Cancer

    NCT00500110 · Phase 2 · Completed

    Posted results

  49. Salvage Therapeutic Radiation With Enzalutamide and ADT in Men With Recurrent Prostate Cancer (STREAM)

    NCT02057939 · Phase 2 · Completed

    Posted results

  50. Pazopanib Hydrochloride After Leuprolide Acetate or Goserelin Acetate in Treating Patients With Relapsed Prostate Cancer

    NCT00454571 · Phase 2 · Completed

    Posted results

How PepBank reports evidence